Central Pacific Bank - Trust Division’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2
Closed -$84 – 854
2026
Q2
$84 Buy
+2
New +$64 ﹤0.01% 878

Other funds holding ARKG

Central Pacific Bank - Trust Division's ARKG Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2026, closing a stake of 2 shares — an estimated $84 sold.

Central Pacific Bank - Trust Division first reported a position in ARKG in Q2 2026 and held it in 1 quarter. The position peaked at $84 in Q2 2026. 8 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Central Pacific Bank - Trust Division reported no remaining ARK Genomic Revolution ETF position as of Q3 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 2 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $84.
  • Central Pacific Bank - Trust Division first reported a position in ARK Genomic Revolution ETF in Q2 2026 and held it in 1 quarter.
  • Central Pacific Bank - Trust Division's ARK Genomic Revolution ETF position peaked at $84 in Q2 2026.
  • 8 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.